LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

Tiangen Chang, Yingying Cao, Hannah J. Sfreddo, Saugato Rahman Dhruba, Se‐Hoon Lee, Cristina Valero, Seong‐Keun Yoo, Diego Chowell, Luc G.T. Morris, Eytan Ruppin